ProNeurogen, Inc.
PrivateLast Round
Grant
Nov 15, 2023
Total Funding Raised
$1.94M
Company Overview
ProNeurogen, Inc. is a biotechnology company that develops novel peptide-based therapeutics to treat vascular dementia, cognitive impairment, and inflammation-related brain disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProNeurogen, Inc. Comparables
Compare ProNeurogen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Constant Therapeutics | 80% | |
| NeuroTherapia, Inc. | 78% | |
| Longevity Biotech | 78% | |
ProNeurogen, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 15, 2023 | ||||
| Grant | Sep 18, 2023 | ||||
| Grant | Sep 16, 2020 |
ProNeurogen, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Aging | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 84% MoM, from 113 to 208.
- Jan 26, 2025
Monthly visitors grew 31% MoM.
ProNeurogen, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ProNeurogen, Inc.'s valuation, stock price, and market status.